In contrast to neurodegerative ailments and cancer, the contribution of TG2 activity to celiac sprue pathogenesis has become rather perfectly founded. The deamidation of specific glutamine residues specific by TG2 in gluten peptides has long been revealed to reinforce peptide binding on the ailment-